Phloretin Attenuates Listeria Monocytogenes Virulence Both in Vitro and in Vivo by Simultaneously Targeting Listeriolysin O and Sortase A

Jianfeng Wang,Bowen Liu,Zihao Teng,Xuan Zhou,Xiyan Wang,Bing Zhang,Gejin Lu,Xiaodi Niu,Yongjun Yang,Xuming Deng
DOI: https://doi.org/10.3389/fcimb.2017.00009
IF: 6.073
2017-01-01
Frontiers in Cellular and Infection Microbiology
Abstract:The critical roles of sortase A (SrtA) and listeriolysin O (LLO) in Listeria monocytogenes pathogenicity render these two virulence factors as ideal targets for the development of anti-virulence agents against L. monocytogenes infection. Additionally, the structures of SrtA and LLO are highly conserved among the members of sortase enzyme family and cholesterol dependent toxin family. Here, phloretin, a natural polyphenolic compound derived from apples and pears that has little anti-L. monocytogenes activity, was identified to simultaneously inhibit LLO expression and neutralize SrtA catalytic activity. Phloretin neutralized SrtA activity by causing a conformational change in the protein's active pocket, which prevented engagement with its substrate. Treatment with phloretin simultaneously reduced L. monocytogenes invasion into host cells and blocked the escape of vacuole-entrapped L. monocytogenes into cytoplasm. Further, L. monocytogenes-infected mice that received phloretin showed lower mortality, decreased bacterial burden and reduced pathological injury. Our results demonstrate that phloretin is a promising anti-infective therapeutic for infections caused by L. monocytogenes due to its simultaneous targeting of SrtA and LLO, which may result in fewer side effects than those caused by other antibiotics.
What problem does this paper attempt to address?